相关实验视频

Updated: Jan 16, 2026

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

FLT3突变AML的代谢特征:临床和治疗影响

Cristina Banella¹, Gianfranco Catalano^2,3, Maura Calvani¹

¹Department of Pediatric Hematology-Oncology, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.

Journal of personalized medicine

|September 26, 2025

概括

代谢重编程推动了急性髓性白血病 (AML) 的生长和抵抗. 针对代谢变化,特别是FLT3突变AML,为这种侵略性癌症提供了新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症新陈代谢癌症新陈代谢

背景情况:

急性髓性白血病 (AML) 是一种复杂的癌症,结果不佳,特别是在老年人中.
下一代测序揭示了AML的显著遗传异质性.
代谢重编程越来越被认为是AML细胞存活率和治疗耐药性的关键因素.

研究的目的:

审查代谢重编程在AML中的作用,重点关注遗传异质性.
探索FLT3突变的AML中的特定代谢变化.
讨论潜在的治疗策略,针对AML中的代谢依赖性.

主要方法:

对AML遗传学,新陈代谢和治疗研究的文献综述.
分析基因突变 (例如FLT3,NPM1,IDH) 和代谢表型之间的相互作用.
综合目前关于AML代谢脆弱性的研究.

主要成果:

不同的AML亚型表现出与其遗传改变相关的独特代谢特征.
FLT3-ITD突变与活性氧物种 (ROS) 的增加和能量代谢的改变有关.
代谢可塑性有助于AML的侵略性和对传统疗法的抵抗性.

结论:

代谢重编程是AML的一个关键标志,受遗传异质性的影响.
FLT3驱动的代谢重新连接为新型AML疗法提供了一个有希望的目标.
开发针对新陈代谢的策略对于改善FLT3突变AML的治疗结果至关重要.

关键词:

在急性髓性白血病中,急性骨髓性白血病在FLT3-ITDD中使用.代谢性可塑性代谢性可塑性代谢向是指代谢向.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...